DarioHealth Corp (DRIO)vsVeeva Systems Inc Class A (VEEV)
DRIO
DarioHealth Corp
$7.30
-5.78%
HEALTHCARE · Cap: $71.17M
VEEV
Veeva Systems Inc Class A
$230.47
+5.82%
HEALTHCARE · Cap: $33.10B
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 15563% more annual revenue ($3.32B vs $21.19M). VEEV leads profitability with a 28.4% profit margin vs -192.2%. VEEV earns a higher WallStSmart Score of 69/100 (B-).
DRIO
Avoid23
out of 100
Grade: F
VEEV
Strong Buy69
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+9.9%
Fair Value
$12.21
Current Price
$7.30
$4.91 discount
Margin of Safety
+38.9%
Fair Value
$289.59
Current Price
$230.47
$59.12 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Every $100 of equity generates 101 in profit
Strong operational efficiency at 30.9%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 28 of every $100 in revenue as profit
Growing faster than its price suggests
16.3% revenue growth
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Revenue declined 17.3%
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : DRIO
The strongest argument for DRIO centers on Price/Book, Return on Equity.
Bull Case : VEEV
The strongest argument for VEEV centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 28.4% and operating margin at 30.9%. Revenue growth of 16.3% demonstrates continued momentum.
Bear Case : DRIO
The primary concerns for DRIO are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio.
Key Dynamics to Monitor
DRIO profiles as a turnaround stock while VEEV is a growth play — different risk/reward profiles.
DRIO carries more volatility with a beta of 1.12 — expect wider price swings.
VEEV is growing revenue faster at 16.3% — sustainability is the question.
VEEV generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (69/100 vs 23/100), backed by strong 28.4% margins and 16.3% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DarioHealth Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
DarioHealth Corp. The company is headquartered in New York, New York.
Visit Website →Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?